Excerpted from the speech of Director Su Zhiyong in Health News and the 4th National Thoracic Surgeons Forum Pathway management is an extremely scientific management method to improve the level of disease diagnosis, reduce the rate of misdiagnosis and misdiagnosis, reduce medical costs, avoid patients spending money on detours, and thus reduce medical disputes. Although the pathway can regulate the diagnosis and treatment behavior and avoid wasting resources, but before that how to build a pathway management platform for early intervention of thoracic surgery with multidisciplinary participation, and do a good job of the first screening, the first consultation, the clinical diagnosis pathway of surgical priority, will save resources to a greater extent and shorten the course of cure. Even reduce the rate of misdiagnosis and mistreatment. Chifeng College Hospital cardiothoracic surgery Su Zhiyong due to many years of direct and microscopic surgery experience, chest anatomy mastery, so that the thoracic surgeons in mastering a variety of advanced means of diagnosis and treatment such as: lung puncture, soft and hard tracheoscopy, thoracoscopy, mediastinoscopy and other modern diagnostic techniques, through the use of relative to other departments, more relaxed more daring, more minimally invasive tissue biopsy methods, more early to uncover the mystery of the disease In addition, it avoids the long time of waiting, looking, trying, treating, delaying treatment, ineffective treatment, and even misdiagnosis and misdiagnosis through images, and avoids the delay of simple chest diseases to complication, which can be solved by minimally invasive means to the necessity of open-heart surgery, and the delay of lung cancer patients who can be resected radically at an early stage to the enlargement of lung lobes and total lung resection, and even to the short survival period by radiotherapy. . In addition to the medical conditions patients self-discovery, self-care delayed consultation, we can cite many such far from isolated cases within the attending hospitals, and not only occur in primary hospitals, for example, many thoracoscopic surgical experience conclusively tells us that part of the pleural effusion can adhere to the honeycomb parcel in a few days, and many primary care physicians in this part of the patients are still applying a lot of antibiotics hormones while With a fine needle obsessive puncture, such as spending tens of thousands of dollars, zapping the patient’s pain, and finally turn to find the thoracic surgery, lost early minimally invasive lumpectomy opportunities, inevitably formed a chronic package, only open-chest surgery, and many also mixed with a lot of unknown causes of pleural fluid such as: cancerous tuberculous pleural fluid, so that patients feel helpless torment medical really foggy, spend a lot of money, take a lot of detours Patients are often confused why we are not allowed to go to thoracic surgery early after treatment and recovery. The differences in treatment concepts, inevitable departmental benefits of physician interests entanglement, more so, many patients are trapped in a complex maze of circuitous pathways, in the attempted treatment, painful bewilderment to try the impossible cure, the rise of pathway medical management, seems to make people feel the light, how? By whom? To build this multidisciplinary joint participation platform, the development of thoracic surgery priority intervention, early diagnosis and treatment, reasonable referral and consultation system medical pathway platform seems imminent, multidisciplinary cross-over disease allows doctors to fight a war of words between disciplinary concepts, such as early isolated lung lesions more than 50% is malignant, the development of minimally invasive surgery for such diseases to provide a safe and effective early diagnosis and treatment, but the reality is However, the reality is that thoracic surgery and respiratory medicine, in the treatment of chest diseases such as pleura-pulmonary mediastinum, intersect very widely, and patients should often go to respiratory medicine first for coughing and shortness of breath and coughing up blood. Every year, there are many cases in which the best first-line treatment is delayed and the patients are transferred to thoracic surgery after several twists and turns. And many realistic problems tell us: many professions are talking to themselves, singing and performing, is there a mechanism path, let everyone sit down to scientifically develop a common standard, how long to observe the trial for how long? Is there a mechanism to avoid the real-life tragedy of “look at the tumor quietly changing”? Therefore, we summarize the following clinical pathways for early intervention and referral in thoracic surgery: diseases in which thoracic surgeons intervene first: various thoracic trauma, pneumothorax, pneumothorax, hemothorax, pleural tumors, pulmonary occupations of any cause, mediastinal occupations, benign and malignant diseases of esophagus and pericardium, various congenital diseases of lung, esophagus, mediastinum and pericardium. Delayed early intervention: various pleural effusions B ultrasound showing cellular parcels, unexplained pleural fluid, recurrent pneumonia, various pleural pulmonary septic diseases in patients with prolonged disease, resectable herpetic emphysema disease in total. At present, China’s regional medical development is uneven, especially in primary hospitals, the lack of unified standards for medical practice, how to treat, what to treat, how long to treat are all up to the doctor, which leads to “excessive medical treatment” and “rash medical treatment” phenomenon, not only wasting medical resources but also harming the interests of patients. This has led to the phenomenon of “excessive medical treatment” and “rash medical treatment”, which not only wastes medical resources but also harms patients’ interests. In the event of medical disputes, the lack of norms does not allow for an authoritative and fair judgment. In addition, with the expansion of China’s medical insurance coverage and the implementation of the off-site reimbursement system, there is an urgent need for medical insurance agencies to develop unified standards for medical benefits and reimbursement. Although the various organizations and measures have different characteristics, their goals are the same: to reduce the waste of medical expenses. It calls for the establishment of a clinical pathway platform for early intervention in thoracic surgery with multidisciplinary participation in the diagnosis and treatment of thoracic diseases by managers at all levels.